Malignant Neoplasm of Stomach Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Cancer, Gastric / Gastric Malignancies / Stomach Cancer / Gastric Cancers / Gastric Cancer / Gastric malignancy / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified

DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting2 IdentifierTitlePurposeDrugs
NCT03448835Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Treatment
NCT03505320A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) AdenocarcinomaTreatment
NCT04379596Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2+ Gastric Cancer (DESTINY-Gastric03)Treatment
NCT03950271SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction AdenocarcinomaTreatment
NCT04354662Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric CancerTreatment
NCT03283761FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaTreatment
NCT03878472Neoadjuvant Immunotherapy for Resectable Gastric CancerTreatment
NCT03421288Phase II Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJTreatment
NCT02954536Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) CancerTreatment
NCT04065282The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.Treatment
NCT04250948Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric CancerTreatment
NCT04062656Perioperative Chemotherapy vs Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEGTreatment
NCT02931890Multicentric Randomised Trial for Resectable Gastric CancerTreatment
NCT03263741Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerTreatment
NCT03817411Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ CancerTreatment
NCT03007446The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric CancerTreatment
NCT02725424Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal CancerTreatment
NCT01665274Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric CancerTreatment
NCT01679340A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 SurgeryPrevention
NCT02250209T- XELOX in HER2-positive Stage III Gastric Cancer After D2 GastrectomyTreatment
NCT02504229DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentTreatment